# Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

> **NCT06880289** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 91 (estimated)

## Conditions studied

- Squamous Cell Tumors of the Head and Neck

## Interventions

- **DRUG:** Cisplatin IV on days 1, 22, 43, at a dose of 100 mg/m2

## Key facts

- **NCT ID:** NCT06880289
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-09-16
- **Primary completion:** 2024-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 91 (ESTIMATED)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06880289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06880289, "Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06880289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*